Biomimetic and soft lab-on-a-chip platform based on enzymatic-crosslinked silk fibroin hydrogel for 3D cell co-culture.

Mariana R Carvalho, David Caballero, Subhas C Kundu, Rui L Reis, Joaquim M Oliveira
{"title":"Biomimetic and soft lab-on-a-chip platform based on enzymatic-crosslinked silk fibroin hydrogel for 3D cell co-culture.","authors":"Mariana R Carvalho, David Caballero, Subhas C Kundu, Rui L Reis, Joaquim M Oliveira","doi":"10.1088/1748-605X/ad8829","DOIUrl":null,"url":null,"abstract":"<p><p>Integrating biological material within soft microfluidic systems made of hydrogels offers countless possibilities in biomedical research to overcome the intrinsic limitations of traditional microfluidics based on solid, non-biodegradable, and non-biocompatible materials. Hydrogel-based microfluidic technologies have the potential to transform<i>in vitro</i>cell/tissue culture and modeling. However, most hydrogel-based microfluidic platforms are associated with device deformation, poor structural definition, reduced stability/reproducibility due to swelling, and a limited range in rigidity, which threatens their applicability. Herein, we describe a new methodological approach for developing a soft cell-laden microfluidic device based on enzymatically-crosslinked silk fibroin (SF) hydrogels. Its unique mechano-chemical properties and high structural fidelity, make this platform especially suited for<i>in vitro</i>disease modelling, as demonstrated by reproducing the native dynamic 3D microenvironment of colorectal cancer and its response to chemotherapeutics in a simplistic way. Results show that from all the tested concentrations, 14 wt% enzymatically-crosslinked SF microfluidic platform has outstanding structural stability and the ability to perfuse fluid while displaying<i>in vivo</i>-like biological responses. Overall, this work shows a novel technique to obtain an enzymatically-crosslinked SF microfluidic platform that can be employed for developing soft lab-on-a-chip<i>in vitro</i>models.</p>","PeriodicalId":72389,"journal":{"name":"Biomedical materials (Bristol, England)","volume":" ","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2024-10-24","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Biomedical materials (Bristol, England)","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1088/1748-605X/ad8829","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

Integrating biological material within soft microfluidic systems made of hydrogels offers countless possibilities in biomedical research to overcome the intrinsic limitations of traditional microfluidics based on solid, non-biodegradable, and non-biocompatible materials. Hydrogel-based microfluidic technologies have the potential to transformin vitrocell/tissue culture and modeling. However, most hydrogel-based microfluidic platforms are associated with device deformation, poor structural definition, reduced stability/reproducibility due to swelling, and a limited range in rigidity, which threatens their applicability. Herein, we describe a new methodological approach for developing a soft cell-laden microfluidic device based on enzymatically-crosslinked silk fibroin (SF) hydrogels. Its unique mechano-chemical properties and high structural fidelity, make this platform especially suited forin vitrodisease modelling, as demonstrated by reproducing the native dynamic 3D microenvironment of colorectal cancer and its response to chemotherapeutics in a simplistic way. Results show that from all the tested concentrations, 14 wt% enzymatically-crosslinked SF microfluidic platform has outstanding structural stability and the ability to perfuse fluid while displayingin vivo-like biological responses. Overall, this work shows a novel technique to obtain an enzymatically-crosslinked SF microfluidic platform that can be employed for developing soft lab-on-a-chipin vitromodels.

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
基于酶交联丝纤维素水凝胶的仿生软芯片实验室平台,用于三维细胞共培养。
在由水凝胶制成的软性微流体系统中集成生物材料,为生物医学研究提供了无数可能性,从而克服了基于固体、不可生物降解和非生物相容性材料的传统微流体技术的内在局限性。基于水凝胶的微流体技术有可能改变体外细胞/组织培养和模型制作。然而,大多数基于水凝胶的微流体平台都存在装置变形、结构清晰度差、因溶胀而导致稳定性/可重复性降低以及刚性范围有限等问题,这威胁着它们的适用性。在此,我们介绍了一种基于酶交联丝纤维素水凝胶的软细胞载体微流体装置的新方法。其独特的机械化学特性和高结构保真度使这一平台特别适用于体外疾病建模,以简单的方式再现了结直肠癌的原生动态三维微环境及其对化疗药物的反应。结果表明,在所有测试浓度中,14wt% 的酶交联丝纤维素微流体平台具有出色的结构稳定性和流体灌注能力,同时显示出类似活体的生物反应。总之,这项工作展示了一种获得酶交联丝纤维素微流控平台的新技术,该平台可用于开发软芯片实验室体外模型。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
自引率
0.00%
发文量
0
期刊最新文献
Osteogenesis promotion on MC3T3 by micro-area potential difference (MAPD) on titanium alloy. An aligned pattern sponge based on gelatin for rapid hemostasis. 3D printedβ-TCP scaffolds loaded with SVVYGLR peptide for promoting revascularization and osteoinduction. Biomaterials for bone tissue engineering: achievements to date and future directions. Inhibition of hepatocellular carcinoma progression by methotrexate-modified pH-sensitive sorafenib and Schisandrin B micelles.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1